Accenture makes strategic investment in Earli
by
Contributor since / Followers
Contributor since / Followers
3 months ago
JHVEPhoto/iStock Editorial via Getty Images
- Accenture (NYSE:ACN) said it has made a strategic investment in Earli.
- Earli is a biotechnology company that developed a novel approach to early cancer detection.
- The investment will support expanding collaborations with global health and pharma companies that can use Earli’s technology to more rapidly and accurately detect and treat cancer.
- Terms of the investment were not disclosed.